Loading...
MCOV B logo

Medicover AB (publ)OM:MCOV B Stock Report

Market Cap SEK 38.5b
Share Price
SEK 255.00
My Fair Value
SEK 272.51
6.4% undervalued intrinsic discount
1Y35.9%
7D-1.4%
Portfolio Value
​
View

Medicover AB (publ)

OM:MCOV B Stock Report

Market Cap: SEK 38.5b

Medicover (MCOV B) Stock Overview

Provides healthcare and diagnostic services in Poland, Sweden, and internationally. More details

MCOV B fundamental analysis
Snowflake Score
Valuation2/6
Future Growth5/6
Past Performance4/6
Financial Health1/6
Dividends0/6

Rewards

Trading at 63.8% below our estimate of its fair value

Earnings are forecast to grow 29.93% per year

Earnings grew by 87.9% over the past year

Risk Analysis

Interest payments are not well covered by earnings

Significant insider selling over the past 3 months


MCOV B Community Fair Values

Create Narrative

See what 9 others think this stock is worth. Follow their fair value or set your own to get alerts.

MCOV B logo
Medicover

Demographic Shifts And Digitalization Will Unlock Healthcare Opportunity

Key Takeaways Demographic trends, market shifts to private healthcare, and focus on diagnostics drive recurring revenue and longer-term patient retention for Medicover. Acquisition integration, digitalization, and service diversification improve margins, operational efficiency, and earnings scalability across expanding hospital and diagnostics networks.
View narrative
SEK 267.22
FV
4.6% undervalued intrinsic discount
11.82%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
4users have followed this narrative
30 days ago author updated this narrative
MCOV B logo
Medicover

Digitalization And Diagnostics Will Unlock Secular Private Healthcare Growth

Key Takeaways Margin expansion and earnings growth are outpacing expectations, driven by fast integration of acquisitions, efficiency gains, and digital transformation. Medicover is positioned for continued growth due to rising healthcare demand in key markets and its scalable, consolidation-focused strategy.
View narrative
SEK 325.27
FV
21.6% undervalued intrinsic discount
15.16%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
23 days ago author updated this narrative
MCOV B logo
Medicover

Rising European Labor Costs And Regulatory Burdens Will Squeeze Margins

Key Takeaways Sustained cost pressures, workforce shortages, and integration issues threaten Medicover's margins and ability to achieve expected synergies from acquisitions. Heightened regulatory, technological, and macroeconomic risks may limit efficiency gains and expose Medicover to market share loss and volatile revenue growth.
View narrative
SEK 219.05
FV
16.4% overvalued intrinsic discount
8.74%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
about 1 month ago author updated this narrative
View Stock Community

Medicover AB (publ) Competitors

Price History & Performance

Summary of share price highs, lows and changes for Medicover
Historical stock prices
Current Share PriceSEK 255.00
52 Week HighSEK 295.00
52 Week LowSEK 170.40
Beta1.57
1 Month Change-2.11%
3 Month Change-2.49%
1 Year Change35.93%
3 Year Change111.44%
5 Year Change91.73%
Change since IPO289.31%

Recent News & Updates

Medicover (STO:MCOV B) Might Have The Makings Of A Multi-Bagger

Sep 24
Medicover (STO:MCOV B) Might Have The Makings Of A Multi-Bagger

Medicover AB (publ) (STO:MCOV B) Not Lagging Industry On Growth Or Pricing

Sep 01
Medicover AB (publ) (STO:MCOV B) Not Lagging Industry On Growth Or Pricing

Medicover AB (publ) Just Beat EPS By 18%: Here's What Analysts Think Will Happen Next

Jul 27
Medicover AB (publ) Just Beat EPS By 18%: Here's What Analysts Think Will Happen Next

Recent updates

Medicover (STO:MCOV B) Might Have The Makings Of A Multi-Bagger

Sep 24
Medicover (STO:MCOV B) Might Have The Makings Of A Multi-Bagger

Medicover AB (publ) (STO:MCOV B) Not Lagging Industry On Growth Or Pricing

Sep 01
Medicover AB (publ) (STO:MCOV B) Not Lagging Industry On Growth Or Pricing

Medicover AB (publ) Just Beat EPS By 18%: Here's What Analysts Think Will Happen Next

Jul 27
Medicover AB (publ) Just Beat EPS By 18%: Here's What Analysts Think Will Happen Next

Medicover (STO:MCOV B) Seems To Use Debt Quite Sensibly

Jul 22
Medicover (STO:MCOV B) Seems To Use Debt Quite Sensibly

Medicover's (STO:MCOV B) Earnings May Just Be The Starting Point

May 09
Medicover's (STO:MCOV B) Earnings May Just Be The Starting Point

Medicover AB (publ)'s (STO:MCOV B) Intrinsic Value Is Potentially 41% Above Its Share Price

Apr 28
Medicover AB (publ)'s (STO:MCOV B) Intrinsic Value Is Potentially 41% Above Its Share Price

Investors Interested In Medicover AB (publ)'s (STO:MCOV B) Revenues

Apr 14
Investors Interested In Medicover AB (publ)'s (STO:MCOV B) Revenues

Medicover (STO:MCOV B) Might Be Having Difficulty Using Its Capital Effectively

Mar 21
Medicover (STO:MCOV B) Might Be Having Difficulty Using Its Capital Effectively
User avatar

New Investments In India's And Romania's Healthcare Services Will Expand Future Global Reach

Strong cash generation supports debt reduction and further investments, boosting future earnings growth positively.

Medicover AB (publ)'s (STO:MCOV B) Popularity With Investors Is Clear

Dec 12
Medicover AB (publ)'s (STO:MCOV B) Popularity With Investors Is Clear

The Strong Earnings Posted By Medicover (STO:MCOV B) Are A Good Indication Of The Strength Of The Business

Nov 07
The Strong Earnings Posted By Medicover (STO:MCOV B) Are A Good Indication Of The Strength Of The Business

Here's What To Make Of Medicover's (STO:MCOV B) Decelerating Rates Of Return

Oct 24
Here's What To Make Of Medicover's (STO:MCOV B) Decelerating Rates Of Return

Investors Appear Satisfied With Medicover AB (publ)'s (STO:MCOV B) Prospects

Apr 22
Investors Appear Satisfied With Medicover AB (publ)'s (STO:MCOV B) Prospects

Additional Considerations Required While Assessing Medicover's (STO:MCOV B) Strong Earnings

Apr 04
Additional Considerations Required While Assessing Medicover's (STO:MCOV B) Strong Earnings

Medicover (STO:MCOV B) Has A Pretty Healthy Balance Sheet

Mar 05
Medicover (STO:MCOV B) Has A Pretty Healthy Balance Sheet

Medicover AB (publ)'s (STO:MCOV B) Intrinsic Value Is Potentially 31% Above Its Share Price

Feb 11
Medicover AB (publ)'s (STO:MCOV B) Intrinsic Value Is Potentially 31% Above Its Share Price

Returns On Capital At Medicover (STO:MCOV B) Paint A Concerning Picture

Dec 20
Returns On Capital At Medicover (STO:MCOV B) Paint A Concerning Picture

Does Medicover (STO:MCOV B) Have A Healthy Balance Sheet?

Dec 02
Does Medicover (STO:MCOV B) Have A Healthy Balance Sheet?

Medicover's (STO:MCOV B) Returns On Capital Not Reflecting Well On The Business

Sep 12
Medicover's (STO:MCOV B) Returns On Capital Not Reflecting Well On The Business

Medicover (STO:MCOV B) Has A Somewhat Strained Balance Sheet

Aug 21
Medicover (STO:MCOV B) Has A Somewhat Strained Balance Sheet

Is There An Opportunity With Medicover AB (publ)'s (STO:MCOV B) 37% Undervaluation?

Jun 12
Is There An Opportunity With Medicover AB (publ)'s (STO:MCOV B) 37% Undervaluation?

Medicover (STO:MCOV B) Will Want To Turn Around Its Return Trends

May 27
Medicover (STO:MCOV B) Will Want To Turn Around Its Return Trends

Is Medicover (STO:MCOV B) Using Too Much Debt?

May 12
Is Medicover (STO:MCOV B) Using Too Much Debt?

Returns On Capital At Medicover (STO:MCOV B) Have Hit The Brakes

Feb 16
Returns On Capital At Medicover (STO:MCOV B) Have Hit The Brakes

Shareholder Returns

MCOV BSE HealthcareSE Market
7D-1.4%-1.5%2.7%
1Y35.9%35.9%-1.2%

Return vs Industry: MCOV B underperformed the Swedish Healthcare industry which returned 37.4% over the past year.

Return vs Market: MCOV B exceeded the Swedish Market which returned -1.7% over the past year.

Price Volatility

Is MCOV B's price volatile compared to industry and market?
MCOV B volatility
MCOV B Average Weekly Movement3.8%
Healthcare Industry Average Movement4.5%
Market Average Movement5.8%
10% most volatile stocks in SE Market12.1%
10% least volatile stocks in SE Market3.0%

Stable Share Price: MCOV B has not had significant price volatility in the past 3 months compared to the Swedish market.

Volatility Over Time: MCOV B's weekly volatility (4%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
199547,000John Stubbingtonwww.medicover.com

Medicover AB (publ) provides healthcare and diagnostic services in Poland, Sweden, and internationally. Its Healthcare Services include service outpatient and inpatient care; dental services; other services, including non-medical related services, such as sports memberships, benefit cards, and optics, as well as wellness; hospital care; and preventive care services. The company’s Diagnostic Services comprise various tests, including allergy and autoimmune diagnostics, bacteriology, parasitology, biochemistry and immunochemistry, blood group diagnostics/transfusion medicine, tumour markers, clinical chemistry, cytology, haematology, histopathology, human genetics, hygiene, immunology and immunochemistry, infectious diseases, microbiology, molecular biology, and pharmacology/toxicology.

Medicover AB (publ) Fundamentals Summary

How do Medicover's earnings and revenue compare to its market cap?
MCOV B fundamental statistics
Market capSEK 38.50b
Earnings (TTM)SEK 477.18m
Revenue (TTM)SEK 24.83b
80.7x
P/E Ratio
1.6x
P/S Ratio

Is MCOV B overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
MCOV B income statement (TTM)
Revenue€2.26b
Cost of Revenue€1.75b
Gross Profit€508.60m
Other Expenses€465.20m
Earnings€43.40m

Last Reported Earnings

Jun 30, 2025

Next Earnings Date

Nov 05, 2025

Earnings per share (EPS)0.29
Gross Margin22.52%
Net Profit Margin1.92%
Debt/Equity Ratio184.8%

How did MCOV B perform over the long term?

See historical performance and comparison

Dividends

0.6%
Current Dividend Yield
52%
Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/10/03 23:51
End of Day Share Price 2025/10/03 00:00
Earnings2025/06/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Medicover AB (publ) is covered by 11 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
null nullABG Sundal Collier
null nullABG Sundal Collier Sponsored
Kristofer Liljeberg-SvenssonCarnegie Investment Bank AB